Salesforce is Nearly Fully Priced: Why Bulls Say This is Just the Beginning

Salesforce's Agentforce ARR surged 240% to $1.5B, with combined AI and data ARR nearing $4B, while shares trade at 27x earnings with a 7% free cash flow yield.

CRM has lagged the S&P 500 badly, sitting down 5% YTD while the index has gained 12%, yet 36 analysts revised FY27 EPS estimates upward in 30 days with zero cuts.

Bears flag a balance sheet transformed by the buyback: noncurrent debt jumped from $10B to $39B, total liabilities nearly doubled, and free cash flow growth is guided at just 4-5%.

Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Salesforce didn't make the cut. Enter your email to see the names that beat CRM. The report is free. Enter your email and see if any of your stocks made the cut.

At $249.12, Salesforce ( NYSE:CRM ) screens attractively. The stock looks fully priced on trailing numbers, yet the AI monetization curve underneath it is bending sharply upward, and the setup into Dreamforce and the September 16, 2026 Investor Day gives bulls a near-term catalyst the market has not fully absorbed.

Salesforce is the world's largest customer relationship management software company, and it has spent the past year retooling itself around agentic AI. Fiscal 2026 revenue reached $41.53 billion, and management is guiding fiscal 2027 to $46.10 billion to $46.40 billion, with a stated $63 billion FY30 target. The stock, however, has lagged. Shares are down 5.47% year to date even after a 29.25% one-month surge tied to the Q2 report.

Why the Agentforce Ramp Changes the Math

The bull argument starts with AI traction that is no longer theoretical. Agentforce ARR crossed $1.5 billion, up over 240% year over year, and combined Agentforce plus Data 360 ARR reached roughly $3.9 billion, up more than 210%. Q2 delivered revenue of $11.35 billion, up 10.83%, and a sixth straight EPS beat.

24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now . Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.

The report is free, and you can see why we think each stock is a top investment today.

Valuation looks reasonable against that growth. Shares trade at roughly 27x trailing earnings with a 7.02% free cash flow yield. The $25 billion accelerated buyback took diluted shares to 821 million from 962 million, and cRPO grew 14% to $33.5 billion, a leading indicator that the second-half reacceleration is real.